ARHGAP6
Basic information
Region (hg38): X:11117651-11665920
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Amelogenesis imperfecta type 1E (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 36 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 14 | 20 | 16 | 55 | ||
Total | 2 | 3 | 50 | 33 | 25 |
Variants in ARHGAP6
This is a list of pathogenic ClinVar variants found in the ARHGAP6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-11118170-A-G | Benign (Apr 09, 2019) | |||
X-11118490-T-C | Likely benign (Mar 10, 2023) | |||
X-11118538-A-G | HCCS-related disorder | Uncertain significance (Feb 23, 2023) | ||
X-11118547-A-G | Inborn genetic diseases | Conflicting classifications of pathogenicity (Apr 09, 2023) | ||
X-11118560-A-C | HCCS-related disorder | Uncertain significance (Dec 01, 2023) | ||
X-11118573-C-T | Benign (Aug 10, 2023) | |||
X-11118574-G-A | Linear skin defects with multiple congenital anomalies 1 | not provided (-) | ||
X-11118588-G-A | HCCS-related disorder | Benign (Mar 31, 2023) | ||
X-11118619-G-T | Linear skin defects with multiple congenital anomalies 1 | Uncertain significance (Jul 13, 2023) | ||
X-11118620-C-T | HCCS-related disorder | Conflicting classifications of pathogenicity (Oct 24, 2018) | ||
X-11118627-A-G | not specified • HCCS-related disorder | Benign/Likely benign (Apr 19, 2023) | ||
X-11120047-T-C | Likely benign (Mar 01, 2023) | |||
X-11120925-A-G | Likely benign (Aug 25, 2022) | |||
X-11120925-A-T | Likely benign (Nov 06, 2023) | |||
X-11120934-C-A | Benign (Feb 01, 2018) | |||
X-11120954-A-G | Inborn genetic diseases | Uncertain significance (Oct 03, 2022) | ||
X-11120974-C-T | Linear skin defects with multiple congenital anomalies 1 | Pathogenic (Nov 01, 2006) | ||
X-11120991-G-C | Uncertain significance (Jan 06, 2024) | |||
X-11120998-G-C | Linear skin defects with multiple congenital anomalies 1 | Uncertain significance (Jul 22, 2023) | ||
X-11121012-GTGT-G | Benign (Jan 24, 2024) | |||
X-11121593-T-C | Likely benign (Jun 04, 2022) | |||
X-11121636-C-T | Likely benign (Jun 20, 2023) | |||
X-11121641-G-C | Pathogenic (Oct 16, 2022) | |||
X-11121652-C-T | Linear skin defects with multiple congenital anomalies 1 • HCCS-related disorder | Likely pathogenic (Feb 27, 2023) | ||
X-11121657-C-T | Benign/Likely benign (Jan 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGAP6 | protein_coding | protein_coding | ENST00000337414 | 13 | 547583 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00155 | 125742 | 1 | 5 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 282 | 382 | 0.738 | 0.0000308 | 6233 |
Missense in Polyphen | 43 | 98.18 | 0.43797 | 1723 | ||
Synonymous | 0.636 | 167 | 178 | 0.939 | 0.0000158 | 2008 |
Loss of Function | 4.52 | 2 | 27.7 | 0.0723 | 0.00000193 | 489 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000134 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000625 | 0.0000462 |
European (Non-Finnish) | 0.0000511 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Could regulate the interactions of signaling molecules with the actin cytoskeleton. Promotes continuous elongation of cytoplasmic processes during cell motility and simultaneous retraction of the cell body changing the cell morphology. {ECO:0000269|PubMed:10699171}.;
- Pathway
- Signal Transduction;rho cell motility signaling pathway;t cell receptor signaling pathway;rac1 cell motility signaling pathway;Rho GTPase cycle;adp-ribosylation factor;Signaling by Rho GTPases;Regulation of RhoA activity
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- 0.326
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.73
Haploinsufficiency Scores
- pHI
- 0.202
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.123
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arhgap6
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; normal phenotype;
Gene ontology
- Biological process
- Rho protein signal transduction;positive regulation of signal transduction;actin filament polymerization;positive regulation of GTPase activity;focal adhesion assembly;regulation of small GTPase mediated signal transduction;negative regulation of stress fiber assembly;negative regulation of focal adhesion assembly
- Cellular component
- cytoplasm;cytosol;actin filament;actin cytoskeleton
- Molecular function
- SH3/SH2 adaptor activity;GTPase activator activity;SH3 domain binding